MicroRNA profiling of multiple osteochondromas: Identification of disease-specific and normal cartilage signatures

Clinical Genetics

Volumn 78, Issue 6, 2010, Pages 507-516

  Zuntini, M ^a   Salvatore, M ^b   Pedrini, E ^a   Parra, A ^a   Sgariglia, F ^a   Magrelli, A ^b   Taruscio, D ^b   Sangiorgi, L ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Articular cartilage; Endochondral ossification signaling pathways; Growth plate cartilage; MicroRNA profiling; Multiple Osteochondromas

Indexed keywords

MICRORNA; MICRORNA 1231; MICRORNA 125B; MICRORNA 126; MICRORNA 1268; MICRORNA 1277; MICRORNA 1308; MICRORNA 140; MICRORNA 145; MICRORNA 148A; MICRORNA 16; MICRORNA 181A; MICRORNA 191; MICRORNA 195; MICRORNA 1978; MICRORNA 1979; MICRORNA 199A; MICRORNA 206; MICRORNA 21; MICRORNA 214; MICRORNA 25; MICRORNA 26B; MICRORNA 451; MICRORNA 483; MICRORNA 498; MICRORNA 575; MICRORNA 638; MICRORNA 658; MICRORNA 939; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADOLESCENT; ADULT; ARTICLE; CARTILAGE; CARTILAGE CELL; CHILD; CHONDROGENESIS; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GENE EXPRESSION; GROWTH PLATE; HEREDITARY MULTIPLE EXOSTOSIS; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; OUTCOME ASSESSMENT; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD;

BONE NEOPLASMS; CARTILAGE; EXOSTOSES, MULTIPLE HEREDITARY; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS;

EID: 78149262630     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2010.01490.x     Document Type: Article

References (70)

1. Khurana J, Abdul-Karim FJ, Bovée VMG. Pathology and genetics of tumours of soft tissue and bone. In: Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization classification of tumours. Lyon: IARC Press, 2002: 234-236.
2. Clément A, Wiweger M, Von Der Hardt S et al. Regulation of zebrafish skeletogenesis by ext2/dackel and papst1/pinscher. PLoS Genet 2008: 4: e1000136.
3. Wicklund CL, Pauli RM, Johnston D et al. Natural history study of hereditary multiple exostoses. Am J Med Genet 1995: 55: 443-446.
4. Schmale GA. Conrad 3rd EU, Raskind WH. The natural history of hereditary multiple exostoses. J. Bone Joint Surg Br 1994: 76: 986-992.
5. Legeai Mallet L, Munnich A, Maroteaux P et al. Incomplete penetrance and expressivity skewing in hereditary multiple exostoses. Clin Genet 1997: 52: 12-16.
6. Bovèe JVMG. Multiple osteochondromas. Orphanet J Rare Dis 2008: 3: 3.
7. Cook A, Raskind W, Blanton SH et al. Heterogeneity in families with hereditary multiple exostoses. Am J Hum Genet 1993: 53: 71-79.
8. Wu YQ, Heutink P, De Vries BB et al. Assignment of a second locus for multiple exostoses to the pericentromeric region of chromosome 11. Hum Mol Genet 1994: 3: 167-171.
9. Wuyts W, Ramlakhan S, Van Hul W et al. Refinement of the multiple exostoses locus (EXT2) to a 3-cM interval on chromosome 11. Am J Hum Genet 1995: 57: 382-387.
10. Jennes I, Pedrini E, Zuntini M et al. Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb). Hum Mutat 2009: 12: 1620-1627.
11. McCormick C, Duncan G, Goutsos KT. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulphate. Proc Natl Acad Sci USA 2000: 97: 668-673.
12. Lind T, Tufaro F, McCormick C et al. The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulphate. J Biol Chem 1998: 273: 26265-26268.
13. Han C, Belenkaja TY, Khodoun M et al. Distinct and collaborative roles of Drosophila EXT family proteins in morphogen signalling and gradient formation. Development 2004: 131: 1563-1575.
14. Takei Y, Ozawa Y, Sato M et al. Three Drosophila EXT genes shape morphogen gradients through synthesis of heparan sulfate proteoglycans. Development 2004: 131: 73-82.
15. Adams SL, Cohen AJ, Lassová L. Integration of signaling pathways regulating chondrocyte differentiation during endochondral bone formation. J Cell Physiol 2007: 213: 635-641.
16. Wuyts W, Van Hul W, De Boulle K et al. Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses. Am J Hum Genet 1998: 62: 346-354.
17. Cheung PK, McCormick C, Crawford BE et al. Etiological point mutations in the hereditary multiple exostoses Gene EXT1: a functional analysis of heparan sulfate polymerase activity. Am J Hum Genet 2001: 69: 55-66.
18. Dobson-Stone C, Cox RD, Lonie L et al. Comparison of fluorescent single-strand conformation polymorphism analysis and denaturing high-performance liquid chromatography for detection of EXT1 and EXT2 mutations in hereditary multiple exostoses. Eur J Hum Genet 2000: 8: 24-32.
19. Porter DE, Lonie L, Fraser M et al. Severity of disease and risk of malignant change in hereditary multiple exostoses. J Bone Joint Surg Br 2004: 86: 1041-1046.
20. Wuyts W, Radersma R, Storm K et al. An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas. Clin Genet 2005: 68: 542-547.
21. Jennes I, Entius MM, Van Hul E et al. Mutation screening of EXT1 and EXT2 by denaturing high-performance liquid chromatography, direct sequencing analysis, fluorescence in situ hybridization, and a new multiplex ligation-dependent probe amplification probe set in patients with multiple osteochondromas. J Mol Diagn 2008: 10: 85-92.
22. Ahn J, Ludecke HJ, Lindow S et al. Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1). Nat Genet 1995: 11: 137-143.
23. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005: 120: 15-20.
24. Erson AE, Petty EM. MicroRNAs in development and disease. Clin Genet 2008: 74: 296-306.
25. Reinhart BJ, Slack FJ, Basson M et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000: 403: 901-906.
26. Wienholds E, Plasterk RH. MicroRNA function in animal development. FEBS Lett 2005: 579: 5911-5922.
27. Dostie J, Mourelatos Z, Yang M et al. Numerous microRNPs in neuronal cells containing novel microRNAs. RNA 2003: 9: 180-186.
28. Chen CZ, Li L, Lodish HF et al. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004: 303: 83-86.
29. Brennecke J, Hipfner DR, Stark A et al. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 2003: 113: 25-36.
30. He L, Thomson JM, Hemann MT et al. A microRNA polycistron as a potential human oncogene. Nature 2005: 435: 828-833.
31. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006: 6: 259-269.
32. Blenkiron C, Miska EA. miRNAs in cancer: approaches, aetiology, diagnostics and therapy. Hum Mol Genet 2007: 16: 106-113.
33. Volinia S, Calin GA, Liu CG et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006: 103: 2257-2261.
34. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006: 6: 857-866.
35. Cho WC. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 2010: 8: 1273-1281.
36. Mitchell PS, Parkin RK, Kroh BEM et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008: 105: 10513-10518.
37. Lodes MJ, Caraballo M, Suciu D et al. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One 2009: 4: e6229.
38. Lin EA, Kong L, Bai X et al. miR-199a, a bone morphogenic protein 2-responsive MicroRNA, regulates chondrogenesis via direct targeting to Smad1. J Biol Chem 2009: 284: 11326-11335.
39. Miyaki S, Nakasa T, Otsuki S et al. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum 2009: 60: 2723-2730.
40. Yamasaki K, Nakasa T, Miyaki S et al. Expression of MicroRNA-146a in osteoarthritis cartilage. Arthritis Rheum 2009: 60: 1035-1041.
41. Tuddenham L, Wheeler G, Ntounia-Fousara S et al. The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett 2006: 580: 4214-4217.
42. Tardif G, Hum D, Pelletier JP et al. Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes. BMC Musculoskelet Disord 2009: 10: 148.
43. Iliopoulos D, Malizos KN, Oikonomou P et al. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One 2008: 3: e3740.
44. Kobayashi T, Lu J, Cobb BS et al. Dicer-dependent pathways regulate chondrocyte proliferation and differentiation. Proc Natl Acad Sci USA 2008: 105: 1949-1954.
45. Baelde HJ, Cleton-Jansen AM, Van Beerendonk H et al. High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma. J Clin Pathol 2001: 54: 778-782.
46. Pedrini E, De Luca A, Valente EM et al. Novel EXT1 and EXT2 mutations identified by DHPLC in Italian patients with multiple osteochondromas. Hum Mutat 2005: 26: 280.
47. Gautier L, Cope L, Bolstad BM et al. Affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004: 20: 307-315.
48. Papadopoulos GL, Alexiou P, Maragkakis M et al. DIANA-mirPath: integrating human and mouse microRNAs in pathways. Bioinformatics 2009: 25: 1991-1993.
49. Rajewsky N. microRNA target predictions in animals. Nat Genet 2006: 38: S8-S13.
50. Negrini M, Ferracin M, Sabbioni S et al. MicroRNAs in human cancer: from research to therapy. J Cell Sci 2007: 120: 1833-1840.
51. Magrelli A, Azzalin G, Salvatore M et al. Altered microRNA expression patterns in hepatoblastoma patients. Transl Oncol 2009: 2: 157-163.
52. Calin GA, Ferracin M, Cimmino A et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005: 353: 1793-1801.
53. Sugatani T, Hruska KA. Impaired micro-RNA pathways diminish osteoclast differentiation and function. J Biol Chem 2009: 284: 4667-4678.
54. Li Z, Hassan MQ, Volinia S et al. A microRNA signature for BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci USA 2008: 105: 13906-13911.
55. Erlebacher A, Filvaroff EH, Gitelman SE et al. Toward a molecular understanding of skeletal development. Cell 1995: 80: 371-378.
56. Karsenty G. Chondrogenesis just ain't what it used to be. J Clin Invest 2001: 107: 405-407.
57. Mackie EJ, Ahmed YA, Tatarczuch L et al. Endochondral ossification: how cartilage is converted into bone in developing skeleton. Int J Biochem Cell Biol 2007: 40: 46-62.
58. Lai LP, Mitchell J. Indian hedgehog: its role and regulation in endochondral bone development. J. Cell Biochem 2005: 96: 1163-1173.
59. Naski MC, Ornitz DM. FGF signaling in skeletal development.. Front Biosci 1998: 3: 781-794.
60. Goldring MB, Tsuchimochi K, Ijiri K. The control of chondrogenesis. J Cell Biochem 2006: 97: 33-44.
61. Nadanaka S, Kitagawa H. Heparan sulphate biosynthesis and disease. J Biochem 2008: 144: 7-14.
62. Duncan G, McCormick C, Tufaro F. The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins. J Clin Invest 2001: 108: 511-516.
63. Hecht JT, Hall CR, Snuggs M et al. Heparan sulfate abnormalities in exostosis growth plates. Bone 2002: 31: 199-204.
64. Österholm C, Barczyk MM, Busse M et al. Mutation in the heparan sulfate biosynthesis enzyme EXT1 influences growth factor signaling and fibroblast interactions with the extracellular matrix. 2009: 284: 34935-34943.
65. Hameetman L, Rozeman LB, Lombaerts M et al. Peripheral chondrosarcoma progression is accompanied by decreased Indian Hedgehog signalling. J Pathol 2006: 209: 501-511.
66. Zuntini M, Pedrini E, Parra A et al. Genetic models of osteochondroma onset and neoplastic progression: evidence for mechanisms alternative to EXT genes inactivation. Oncogene 2010: April 26 [Epub ahead of print].
67. Pineau P, Volinia S, McJunkin K et al. miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA 2010: 107: 264-269.
68. Williams AH, Valdez G, Moresi V et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 2009: 326: 1549-1554.
69. Carè A, Catalucci D, Felicetti F et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007: 13: 613-618.
70. Takeshita F, Patrawala L, Osaki M et al. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther 2010: 18: 181-187.